| Literature DB >> 33811269 |
Lauren Mathis1, Danielle Crethers2, Bert Buckman1, Michael Jensen3, Anastasios C Polimenakos4,5.
Abstract
Alternative options for the correction of partial anomalous pulmonary venous connection (PAPVC) have been proposed. Each can be associated with variable risk for dysrhythmias, caval or pulmonary venous (PV) obstruction. A selective customized strategy to address PAPVC taking into account atrial shunt (AS) and growth potential was pursued. Between September 2014 and August 2018 21 PAPVC patients were identified. Two levels of reference determined the chosen repair strategy; azygous vein (AzV) and cavoatrial junction (CAJ). Six (Group-A) with PAPVC entering SVC cephalad to AV underwent a combined in-situ cavoatrial autologous reconstruction with atrial appendage advancement flap (CARAF). PAPVC entering caudally to AzV (Group-B) underwent alternative repair (caval division/Warden-type or intraatrial rerouting) (n = 15). Age was 8.3 (IQR:4.2-18.5) years for Group-A (vs 11.9; IQR:8.8-34.7 in Group-B) (p = 0.07). In Group-A 5(83%) had AS (vs 12[80%] Group-B; p = 0.9). None had left SVC in Group-A (vs 1 in Group-B; p = 0.9). Preoperative advanced imaging and echocardiographic hemodynamic evaluation was undertaken. Follow-up was complete (median 2.9; IQR:1.2-3.7 years). Freedom from atrial dysrhythmias, caval or PV obstruction was assessed. There were no early or late deaths. ICU and hospital length of stay were 1.8 ± 1.1 and 3.2 ± 0.5 days, respectively. No atrial dysrhythmias occurred postoperatively in Group-A (vs 1 in Group-B; p = 0.9). No permanent pacemaker was implanted. All patients remained in normal sinus rhythm. There were no early or late caval/PV obstruction. A customized approach reserves the advantages of each technique tailored to patient's needs. Expanding surgical capacity with favorable outlook for all PAPVC variations, irrespective of association with AS, can maximize efficiency and reproducibility paired with the lowest morbidity.Entities:
Keywords: Outcomes; Partial anomalous pulmonary venous connection; Sinus venosus ASD
Mesh:
Year: 2021 PMID: 33811269 PMCID: PMC8192397 DOI: 10.1007/s00246-021-02583-4
Source DB: PubMed Journal: Pediatr Cardiol ISSN: 0172-0643 Impact factor: 1.655
Fig. 1Indications and customized strategy. CAJ cavoatrial junction, CARAF cavoatrial autologous reconstruction and atrial appendage advancement flap, CIVJ cavoinnominate venous junction, PAPVC partial anomalous pulmonary venous connection
Fig. 2Advanced imaging (MR angiography) and repair strategy. (arrow: indicates the upper anomalous pulmonary venous anatomy and location referenced to the azygous vein). a Pulmonary venous channel was baffled with an oversized domed ovale-shaped autologous pericardium patch through the atrial septal defect into the left atrium; b A diamond-shaped autologous pericardium was used to allow a cephalad advancement of the right atrial(RA) appendage. The systemic venous channel was reconstituted by suturing the amputated tip of the RA appendage to the cephalad(transected) caval segment. c On cardiopulmonary bypass with the heart beating the systemic venous channel is reconstituted by suturing the amputated tip of the RA appendage to the transected caval segment
Patient and operative characteristics
| Variables | Group A ( | Group B ( | |
|---|---|---|---|
| Age (years; median, IQR) | 8.3 (2.2-18.5) | 11.9 (8.8-34.7) | 0.07 |
| Males/Females | 3/3 | 7/8 | |
| Weight at surgery (kg; mean, SD) | 22.5 ± 14.8 | 35.7 ± 13.7 | 0.05 |
| Type of atrial shunt | 0.01 | ||
| A. With | 5 | 12 | |
| 1. SVASD | |||
| 2. Ostium secundum ASD | |||
| 3. PFO | |||
| B. Without | 1 | 3 | |
| Concomitant cardiac anomalies | |||
| 1. VSD | 1 | 0 | 0.8 |
| 2. Pulmonary valve stenosis | 0 | 1 | 0.9 |
| 3. Left SVC | 0 | 1 | 0.9 |
| 4. TV insufficiency (>mild) | 1 | 2 | 0.8 |
| No. of anomalous pulmonary veins | |||
| 1 | 2 | 4 | 0.8 |
| 2 | 4 | 10 | 0.8 |
| 3 | 0 | 1 | 0.9 |
| Location of anomalous pulmonary veins | |||
| 1. Above azygous vein | 6 | 0 | |
| 2. Between azygous vein and atriocaval junction | 0 | 11 | |
| 3. At or below atriocaval junction | 0 | 4 | |
| Presenting diagnosis | |||
| 1. Murmur/asymptomatic | 5 | 9 | 0.1 |
| 2. Symptomatic | 1 | 6 | 0.1 |
| Imaging modality for establishing diagnosis | |||
| 1. TTE | 6 | 15 | |
| 2. MRA | 3 | 9 | |
| 3. CTA | 2 | 4 | |
| 4. Cardiac cath/angiogram | 1 | 2 | |
| Associated extracardiac / chromosomal abnormalities | 1 | 3 | 0.7 |
| CBP (min; mean, SD) | 51.3 ± 18.5 | 54.9 ± 14.8 | 0.8 |
| Cross Clamp (min; mean, SD) | 41.9 ± 10.5 | 46.1 ± 17.5 | 0.1 |
| Type of repair | |||
| Caval division (Warden or modified) | 0 | 11 | |
| CARAF | 6 | 0 | |
| Single-patch | 0 | 4 | |
| Total additional surgical procedures | |||
| Left SVC intervention | 0 | 1¶ | 0.9 |
| ASD creation (enlargement) | 2(1)§ | 5(2)§ | 0.9 |
| TV repair | 1 | 1 | 0.8 |
| VSD repair | 1 | 0 | 0.9 |
| Pulmonary valvotomy | 0 | 1 | 0.9 |
| Intraoperative dysrhythmias | 0 | 1 | 0.9 |
CPB cardiopulmonary bypass, PFO patent foramen ovale, SVASD sinus venosus atrial septal defect, SVC superior vena cava, TV tricuspid valve, VSD ventricular septal defect
§PFO enlargement
¶Unroofed coronary sinus repair
Fig. 3Number of anomalous pulmonary veins involved
Outcomes and follow-up
| Variables | Group A ( | Group B ( | |
|---|---|---|---|
| ICU stay (days; mean, SD) | 1.7 ± 1.2 | 1.9 ± 1.3 | 0.9 |
| Hospital stay (days; mean, SD) | 3.1 ± 0.6 | 3.2 ± 0.4 | 0.9 |
| Post-cardiotomy syndrome | 1 | 0 | 0.8 |
| Complications; other | 0 | 1 | 0.9 |
| Dysrhythmias | 0 | 1 | 0.9 |
| Use of temporary or permanent pacemaker¶ | 0 | 0 | – |
| Sinus rhythm¶ | 6 | 15 | – |
| Systemic venous stenosis/obstruction¶ | 0 | 0 | – |
| Pulmonary venous stenosis/obstruction¶ | 0 | 0 | – |
| TV insufficiency (>mild)¶ | 0 | 1 | 0.9 |
| 30-day readmission | 0 | 0 | |
| Permanent pacemaker§ | 0 | 0 | |
| Dysrhythmias§ | 0 | 0 | |
| Normal sinus rhythm§ | 6 | 15 | |
| Systemic venous stenosis/obstruction§ | 0 | 0 | |
| Pulmonary venous stenosis/obstruction§ | 0 | 0 | |
| TV insufficiency§ | 0 | 1 | |
| Reintervention(any) | 0 | 0 | |
| NYHA class 1 (only in adults) | 2 (of 2) | 0 (of 9) | |
TV tricuspid valve
¶At hospital discharge
§At last follow up
Fig. 4Velocity by echocardiographic doppler assessment of a systemic and b pulmonary venous channels